Journal
ACTA PHARMACOLOGICA SINICA
Volume 40, Issue 4, Pages 460-467Publisher
ACTA PHARMACOLOGICA SINICA
DOI: 10.1038/s41401-018-0033-7
Keywords
metabotropic glutamate receptor 2; insulin-like growth factor 1 receptor; transactivation; FAK; ERK1/2; LY379268; LY487379; mouse cortical neurons
Funding
- National Natural Science Foundation of China (NSFC) [31420103909, 31711530146, 31511130131]
- Program of Introducing Talents of Discipline to the Universities of the Ministry of Education [B08029]
- Natural Science Foundation of Hubei Province [2014CFA010]
- NSFC [31301163]
Ask authors/readers for more resources
Metabotropic glutamate receptor 2 (mGlu2) belongs to the group-II metabotropic glutamate (mGlu) receptors and is a neurotransmitter G protein-coupled receptor. The group-II mGlu receptors are promising antipsychotic targets, but the specific role of mGlu2 signaling remains unclear. Receptor tyrosine kinases (RTKs) are also believed to participate in brain pathogenesis. To investigate whether there is any communication between mGlu2 and RTKs, we generated a CHO-mGlu2 cell line that stably expresses mGlu2 and showed that activation of mGlu2 by LY379268, a group II mGlu agonist, was able to transactivate insulin-like growth factor 1 receptor (IGF-1R). We further determined that the G(i/o) protein, G(beta gamma) subunits, phospholipase C, and focal adhesion kinase (FAK) were involved in the IGF-1R transactivation signaling axis, which further induced the phosphorylation of extracellular signal-regulated kinase1/2 (ERK1/2) and cAMP response element-binding protein. In primary mouse cortical neurons, similar signaling pathways were observed when mGlu2 were stimulated by LY487379, an mGlu2 positive allosteric modulator. Transactivation of IGF-1R through FAK in response to mGlu2 should provide a better understanding of the association of mGlu2 with brain disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available